Ventyx Biosciences, Inc clinical trials
Acquired by Eli Lilly and Company, Mar 4, 2026 · source ↗
The registry lists 3 studies whose lead sponsor is Ventyx Biosciences, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 19, 2026.
- 3studies on the registry
- 0open to participants now
Before and after it joined Eli Lilly and Company
- First submitted before Ventyx Biosciences, Inc became part of Eli Lilly and Company
- 3
- First submitted after Ventyx Biosciences, Inc became part of Eli Lilly and Company
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What changed recently
From the registry's own updates since Oct 21, 2026.
Results posted1
- VTX958 Versus Placebo for the Treatment of Moderate to Severe PsoriasisNov 19, 2026NCT05655299
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Stopped early3100%
Over the years
- 22
- 223
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Ventyx Biosciences, Inc3 studies
Something wrong with this grouping? Tell us on the Eli Lilly and Company page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Eli Lilly and Company studies →
- VTX958 Versus Placebo for the Treatment of Moderate to Severe PsoriasisTerminatedNCT05655299Phase 2
Sponsor listed in the registry: Ventyx Biosciences, Inc · First submitted before Ventyx Biosciences, Inc became part of Eli Lilly and Company
- VTX958 for the Treatment of Moderately to Severely Active Crohn's DiseaseTerminatedNCT05688852Phase 2
Sponsor listed in the registry: Ventyx Biosciences, Inc · First submitted before Ventyx Biosciences, Inc became part of Eli Lilly and Company
- VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)TerminatedNCT05715125Phase 2
Sponsor listed in the registry: Ventyx Biosciences, Inc · First submitted before Ventyx Biosciences, Inc became part of Eli Lilly and Company